Company Valuation: BlossomHill Therapeutics, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2026 2027 2028
Market Cap 1 821.9 - -
Change - - -
Enterprise Value (EV) 821.9 821.9 821.9
Change - 0% 0%
P/E -7.01x -8.15x -7.72x
PBR - - -
PEG 0.3x 0.6x -1.37x
Capitalization / Revenue - - -
EV / Revenue - - -
EV / EBITDA -7.34x -6.04x -5.17x
EV / EBIT -7.76x -6.32x -5.09x
EV / FCF -8.79x -7.27x -8.61x
FCF Yield -11.4% -13.7% -11.6%
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 -3.824 -3.289 -3.474
Distribution rate - - -
Net sales 1 - - -
EBITDA 1 -112 -136 -159
EBIT 1 -106 -130.1 -161.5
Net income 1 -101.2 -121.4 -153.4
Net Debt - - -
Reference price 2 26.82 26.82 26.82
Nbr of stocks (in thousands) 30,644 - -
Announcement Date - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-7.01x - - - 822M
31.85x5.73x17.17x1.02% 46.18B
34.7x3.34x14.42x-.--% 44.35B
-20.15x232.19x-21.56x-.--% 42.21B
46.3x5.35x29.28x-.--% 40.19B
27.32x7.86x20.08x0.42% 29.83B
34.98x5.74x26.08x-.--% 17.17B
25.63x2.2x9.55x1.04% 15.32B
28.8x1.89x11.64x-.--% 13.09B
Average 22.49x 33.04x 13.33x 0.31% 27.68B
Weighted average by Cap. 24.88x 43.57x 12.26x 0.3%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. BLSM Stock
  4. Valuation BlossomHill Therapeutics, Inc.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!